(Q64122637)

English

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

FLUENT (English)

0 references

title

A 12-Month, Prospective, Multicenter, Two-cohort, Nonrandomized, Open-label Study in Adult Patients With Relapsing Multiple Sclerosis (RMS), to Investigate Changes in Immune Phenotype Biomarkers After Treatment With 0.5mg Fingolimod [FLUENT] (English)

0 references

0 references

0 references

0 references

United States of America

0 references